Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Green, Nancy S ^a   Ender, Katherine L ^a   Pashankar, Farzana ^b   Driscoll, Catherine ^c   Giardina, Patricia J ^d   Mullen, Craig A ^e   Clark, Lorraine N ^f   Manwani, Deepa ^c   Crotty, Jennifer ^a   Kisselev, Sergey ^f   Neville, Kathleen A ^g   Hoppe, Carolyn ^h   Barral, Sandra ⁱ  

^a Columbia University ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f Department of Medicine   (United States)

^g CHILDREN S MERCY HOSPITAL   (United States)

^h CHILDREN S HOSPITAL OAKLAND   (United States)

ⁱ Vagelos College of Physicians and Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; BCL11A GENE; CHILD; DRUG EFFICACY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; GLP2R GENE; HAPLOTYPE; HBB GENE; HBE GENE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADOLESCENT; ALLELES; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; FEMALE; FETAL HEMOGLOBIN; GENOTYPE; HUMANS; HYDROXYUREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84873589744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055709     Document Type: Article

References (26)

1. Bunn HF, (1987) Subunit assembly of hemoglobin: an important determinant of hematologic phenotype. Blood 69: 1-6.
2. Powars DR, Weiss JN, Chan LS, Schroeder WA, (1984) Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 63: 921-926.
3. Platt OS, (2008) Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 358: 1362-1369.
4. Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, et al. (2003) Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Am J Hematol 72: 121-126.
5. Thein SL, Menzel S, Lathrop M, Garner C, (2009) Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet 18: R216-223.
6. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, et al. (2010) Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 42: 1049-1051.
7. Lettre G, Sankaran VG, Bezerra MA, Araujo AS, Uda M, et al. (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A 105: 11869-11874.
8. Makani J, Menzel S, Nkya S, Cox SE, Drasar E, et al. (2011) Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 117: 1390-1392.
9. Sebastiani P, Wang L, Nolan VG, Melista E, Ma Q, et al. (2008) Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations. Am J Hematol 83: 189-195.
10. Bhatnagar P, Purvis S, Barron-Casella E, Debaun MR, Casella JF, et al. (2011) Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 56: 316-323.
11. Sedgewick AE, Timofeev N, Sebastiani P, So JC, Ma ES, et al. (2008) BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 41: 255-258.
12. Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, et al. (2012) Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 120: 1961-1962.
13. Ma Q, Wyszynski DF, Farrell JJ, Kutlar A, Farrer LA, et al. (2007) Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J 7: 386-394.
14. Solovieff N, Milton JN, Hartley SW, Sherva R, Sebastiani P, et al. (2010) Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster. Blood 115: 1815-1822.
15. Meier ER, Byrnes C, Weissman M, Noel P, Luban NL, et al. (2011) Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood. Pediatr Blood Cancer 56: 103-109.
16. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, et al. (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 89: 1078-1088.
17. Green NS, Barral S, (2011) Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease. Pediatr Blood Cancer 56: 177-181.
18. Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, et al. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99: 10-14.
19. Ware RE, Despotovic JM, Mortier NA, Flanagan JM, He J, et al. (2011) Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood 118: 4985-4991.
20. Charache S, (1997) Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol 34: 15-21.
21. Kumkhaek C, Taylor JGt, Zhu J, Hoppe C, Kato GJ, et al. (2008) Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia. Br J Haematol 141: 254-259.
22. Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, et al. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 103: 2039-2045.
23. Green NS, Fabry ME, Kaptue-Noche L, Nagel RL, (1993) Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia. Am J Hematol 44: 145-146.
24. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
26. Ender KL, Lee MT, Sheth S, Licursi M, Crotty J, et al. (2011) Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea. J Pediatr Hematol Oncol 33: 496-499.